ESOP27 Aug 2026, 12:46 pm

Aarti Drugs approves Performance Stock Option Plan 2026

AI Summary

Aarti Drugs Limited's Board of Directors has approved the 'Aarti Drugs Limited Performance Stock Option Plan 2026' (PSOP 2026). The plan allows for the creation and grant of up to 8,00,000 Performance Stock Options, convertible into an equal number of equity shares. This is subject to shareholder approval and compliance with SEBI regulations. The board meeting where this was decided commenced at 11:30 AM and concluded at 12:20 PM on August 27, 2026.

Key Highlights

Board approved the Performance Stock Option Plan 2026.
Plan allows for up to 8,00,000 stock options.
Options are convertible into equity shares.
Subject to shareholder and regulatory approval.
Approved during the board meeting on August 27, 2026.

View BSE Filing

AARTIDRUGS

Pharmaceuticals

AARTI DRUGS LTD.

Price Impact